Advertisement

Topics

INCJ, Takeda, and MEDIPAL HOLDINGS Partner to Launch a Biotech Venture

16:04 EDT 14 Mar 2017 | Takeda

Enhancing the international competitiveness of the Japanese pharmaceutical companies by offering spin-off modelTakeda will contribute the research and development portfolio and personnel in the renal, metabolic, and cardiovascular therapeutic areas to support the launch of the new companyThis ventur

Original Article: INCJ, Takeda, and MEDIPAL HOLDINGS Partner to Launch a Biotech Venture

NEXT ARTICLE

More From BioPortfolio on "INCJ, Takeda, and MEDIPAL HOLDINGS Partner to Launch a Biotech Venture"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...